Versant Capital Management’s MapLight Therapeutics MPLT Stock Holding History

Versant Capital Management’s Portfolio MPLT Stock Details MPLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-50	Closed	-$1.79K	–	2890
2026 Q2	$1.79K	Hold	50	–	–	﹤0.01%	2573
2026 Q1	$1.02K	Buy	+50	New	+$894	﹤0.01%	2653

Other funds holding MPLT

Market Street Wealth Management Advisors Indianapolis, Indiana $703M AUM 10.22% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Versant Capital Management's MPLT Position: Q3 2026 in Review

Versant Capital Management sold out of MapLight Therapeutics (MPLT) in Q3 2026, closing a stake of 50 shares — an estimated $1.79K sold.

Versant Capital Management first reported a position in MPLT in Q1 2026 and held it in 2 quarters. The position peaked at $1.79K in Q2 2026. 5 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.

Versant Capital Management reported no remaining MapLight Therapeutics position as of Q3 2026 after selling out during the quarter.
Versant Capital Management sold 50 MapLight Therapeutics shares in Q3 2026, an estimated $1.79K.
Versant Capital Management first reported a position in MapLight Therapeutics in Q1 2026 and held it in 2 quarters.
Versant Capital Management's MapLight Therapeutics position peaked at $1.79K in Q2 2026.
5 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.